 |
|
|
| |
Preclinical Characterization of AL-335, a Potent Uridine Based Nucleoside Polymerase Inhibitor for the Treatment of Chronic Hepatitis C
|
| |
| |
Reported by Jules Levin
AASLD/EASL NY HCV Conference, Sept 12-13 2014
Hua Tan, Kenneth Shaw, Andreas Jekle, Jerome Deval, Zhinan Jin, Amy Fung, Yuen Tam, Lawrence M. Blatt, Sushmita M. Chanda, Guangyi Wang,
Natalia Dyatkina, Marija Prhavc, Caroline Williams, Vlad Serebryany, Qingling Zhang, Julian A. Symons, Leonid Beigelman and David B. Smith*
Alios BioPharma, Inc., 260 E. Grand Avenue, South San Francisco, CA, USA.
|
| |
|
|
|
|
|
